Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04544761 · ClinicalTrials.gov registry record
Resilience in Persons Following Spinal Cord Injury
A clinical trial, sponsored by Shirley Ryan AbilityLab.
- Completed
- Registry status
- 28
- Enrollment target
NCT04544761: Completed study, sponsored by Shirley Ryan AbilityLab.
NCT04544761 is a clinical trial that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04544761 has completed, sponsored by Shirley Ryan AbilityLab.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
This study aims to quantify resilience in survivors of a spinal cord injury. The study will consist of structured interviews and self-reported surveys. We will look for common themes between participants at different stages of injury (1-5 years, 5-15 years, \>15 Years).
Primary Outcome
Common themes from the structured interviews
Interventions
- OTHER Structured Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2020-09-25 |
| Est. Completion | 2024-04-04 |
What the finished NCT04544761 record still lists
NCT04544761 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Structured Interview is the first listed.
NCT04544761 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04544761 about?
NCT04544761 is a clinical study titled "Resilience in Persons Following Spinal Cord Injury". This study aims to quantify resilience in survivors of a spinal cord injury. The study will consist of structured interviews and self-reported surveys. We will look for common themes between participants at different stages of injury (1-5 years, 5-15 years, \>15 Years).
What is the current status of trial NCT04544761?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2020-09-25. Estimated completion is 2024-04-04.
What interventions are being tested in trial NCT04544761?
The interventions under investigation include: Structured Interview (OTHER).
Who is sponsoring clinical trial NCT04544761?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI